Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125492363 | 12549236 | 3 | F | 20160705 | 20160809 | 20160712 | 20160816 | EXP | US-GILEAD-2016-0222721 | GILEAD | 74.00 | YR | E | F | Y | 88.44000 | KG | 20160816 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125492363 | 12549236 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Oral | 10 MG, QD | 1504768A | 22081 | 10 | MG | TABLET | QD | |||||
| 125492363 | 12549236 | 2 | SS | TYVASO | TREPROSTINIL | 1 | Respiratory (inhalation) | 6 BREATHS PER SESSION | Y | 0 | |||||||||
| 125492363 | 12549236 | 3 | SS | TYVASO | TREPROSTINIL | 1 | Respiratory (inhalation) | 3 BREATHS PER SESSION | Y | 0 | |||||||||
| 125492363 | 12549236 | 4 | C | ATORVASTIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 125492363 | 12549236 | 5 | C | BENZONATATE. | BENZONATATE | 1 | 0 | ||||||||||||
| 125492363 | 12549236 | 6 | C | BUMETANIDE. | BUMETANIDE | 1 | 0 | ||||||||||||
| 125492363 | 12549236 | 7 | C | CALTRATE 600+D | 2 | 0 | |||||||||||||
| 125492363 | 12549236 | 8 | C | VITAMINS WITH MINERALS | MINERALSVITAMINS | 1 | 0 | ||||||||||||
| 125492363 | 12549236 | 9 | C | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | 0 | ||||||||||||
| 125492363 | 12549236 | 10 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | 0 | ||||||||||||
| 125492363 | 12549236 | 11 | C | ELIQUIS | APIXABAN | 1 | 0 | ||||||||||||
| 125492363 | 12549236 | 12 | C | FISH OIL | FISH OIL | 1 | 0 | ||||||||||||
| 125492363 | 12549236 | 13 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
| 125492363 | 12549236 | 14 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 125492363 | 12549236 | 15 | C | SILDENAFIL. | SILDENAFIL | 1 | 0 | ||||||||||||
| 125492363 | 12549236 | 16 | C | TIKOSYN | DOFETILIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125492363 | 12549236 | 1 | Pulmonary arterial hypertension |
| 125492363 | 12549236 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125492363 | 12549236 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125492363 | 12549236 | Constipation | |
| 125492363 | 12549236 | Hypotension | |
| 125492363 | 12549236 | Loss of consciousness | |
| 125492363 | 12549236 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125492363 | 12549236 | 1 | 201510 | 0 |